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Abstract 
Background: Bacteriocins produced by lactic acid bacteria (LAB) attract considerable interest as natural and nontoxic 
food preservatives and as therapeutics whereas the bacteriocin-producing LAB are considered potential probiotics for 
food, human and veterinary applications, and in the animal production field. Within LAB the lactobacilli are increas-
ingly used as starter cultures for food preservation and as probiotics. The lactobacilli are also natural inhabitants of the 
gastrointestinal (GI) tract and attractive vectors for delivery of therapeutic peptides and proteins, and for production 
of bioactive peptides. Research efforts for production of bacteriocins in heterologous hosts should be performed if 
the use of bacteriocins and the LAB bacteriocin-producers is ever to meet the high expectations deposited in these 
antimicrobial peptides. The recombinant production and functional expression of bacteriocins by lactobacilli would 
have an additive effect on their probiotic functionality.
Results: The heterologous production of the bacteriocin enterocin A (EntA) was evaluated in different Lactobacillus 
spp. after fusion of the versatile Sec-dependent signal peptide (SPusp45) to mature EntA plus the EntA immunity gene 
(entA + entiA) (fragment UAI), and their cloning into plasmid vectors that permitted their inducible (pSIP409 and 
pSIP411) or constitutive (pMG36c) production. The amount, antimicrobial activity (AA) and specific antimicrobial activ-
ity (SAA) of the EntA produced by Lactobacillus sakei Lb790, Lb. plantarum NC8 and Lb. casei CECT475 transformed 
with the recombinant plasmids pSIP409UAI, pSIP411UAI and pMGUAI varied depending of the expression vector and 
the host strain. The Lb. casei CECT475 recombinant strains produced the largest amounts of EntA, with the highest AA 
and SAA. Supernatants from Lb. casei CECT (pSIP411UAI) showed a 4.9-fold higher production of EntA with a 22.8-fold 
higher AA and 4.7-fold higher SAA than those from Enterococcus faecium T136, the natural producer of EntA. Moreo-
ver, supernatants from Lb. casei CECT475 (pSIP411UAI) showed a 15.7- to 59.2-fold higher AA against Listeria spp. than 
those from E. faecium T136.
Conclusion: Lb. casei CECT457 (pSIP411UAI) may be considered a promising recombinant host and cell factory for 
the production and functional expression of the antilisterial bacteriocin EntA.
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bacteriocin production
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Background
Within lactic acid bacteria (LAB) the lactobacilli are increas-
ingly used as starter cultures for food preservation and as 
probiotics [1]. The lactobacilli are also natural inhabitants 
of the gastrointestinal (GI) tract and attractive vectors for 
delivery of therapeutic peptides and proteins and production 
of bioactive peptides [2, 3]. Furthermore, most probiotics 
enhance intestinal barrier function, display immunomodu-
latory activity and exert protective effects against pathogens 
due to the production of antimicrobial compounds [4–6]. 
Since the in situ production of the antilisterial bacteriocin 
Abp118 is the major reason of the well-documented probi-
otic effect of Lb. salivarius UCC118 against Listeria mono-
cytogenes EFDe infections in mice [7, 8], the production of 
bacteriocins by lactobacilli surely would have an additive 
effect on their probiotic functionality.
Bacteriocins are ribosomally synthesized antimicro-
bial peptides secreted by bacteria, and those produced 
by LAB attract considerable interest as natural and 
nontoxic food preservatives, for human and veterinary 
applications, and in the animal production field [9, 10]. 
Most bacteriocins, including those produced by entero-
cocci and named enterocins are synthesized as biologi-
cally inactive precursors or prepeptides containing an 
N-terminal extension of the so-called double-glycine 
type (leader sequence) that is cleaved concomitantly 
with export across the cytoplasmic membrane by dedi-
cated ATP-binding cassette transporters (ABC trans-
porters) and their accessory proteins [11]. However, 
many secreted prokaryotic proteins and a few bacteri-
ocins contain N-terminal extensions of the Sec-depend-
ent type (signal peptide) that are proteolytically cleaved 
concomitantly with peptide externalization by the gen-
eral secretory pathway (GSP) or Sec-dependent pathway 
[12]. And the signal peptide (SP) of secretory proteins 
and bacteriocins may drive fused mature bacteriocins to 
SPs for their secretion by recombinant LAB [9, 10, 13]. 
The mature bacteriocins are often cationic, amphiphilic 
molecules of 20–60 amino acid residues that are classi-
fied into two main classes: the lantibiotics or class I that 
consist of modified bacteriocins and the class II or non-
modified bacteriocins which are further subdivided in 
class IIa, class IIb, class IIc, and class IId. Among these 
subgroups, the class IIa bacteriocins (also referred to as 
pediocin-like bacteriocins) have attracted much attention 
due to their strong antilisterial activity [14]. Additional 
subgroups have been suggested for leaderless peptides, 
circular bacteriocins, linear peptides derived from large 
proteins, and the glycosylated bacteriocins [15].
Accordingly, bacteriocins with high antimicrobial activ-
ity against bacterial pathogens could be overproduced 
and would contribute to the probiotic effect of recombi-
nant Lactobacillus spp. strains [8, 16]. Enterocin A (EntA) 
is a class IIa bacteriocin whose synthesis is directed by 
the entAIFKRTD operon and from which entA encodes 
the enterocin A prepetide synthesized as an 18 amino 
acid leader sequence of the double-glycine type and the 
47 amino acid mature bacteriocin [17, 18]. Moreover, its 
potent antilisterial activity has driven interest for its over-
production by LAB mostly of the genera Lactococcus, Ente-
rococcus and Pediococcus [13, 19] and also by yeasts from 
the genera Pichia, Kluyveromyces, Hansenula and Arxula, 
throughout fusions of mature EntA to signal peptides (SPs) 
that act as secretion signals [20, 21]. Accordingly, of bio-
technological interest would be the design and construc-
tion of recombinant Lactobacillus spp. for the controlled 
or constitutive heterologous production of bacteriocins 
with high antimicrobial activity against Listeria spp.
In this work, Lb. sakei Lb790 a non-bacteriocin produc-
ing strain from meat origin [22], Lb. plantarum NC8 from 
grass silage encoding the two-peptide plantaricins PlnEF, 
PlnJK and PLNC8αβ of narrow inhibitory spectra [23, 24] 
and Lb. casei CECT475, a reported non-bacteriocin pro-
ducer from dairy origin, were transformed with derivatives 
of the inducible protein expression vectors pSIP409 and 
pSIP411 and the constitutive pMG36c expression vector, 
for evaluation of the production of EntA and its functional 
expression as determined by evaluation of their antimicro-
bial activity against Listeria spp.
Results
Heterologous production and functional expression 
of EntA by different Lactobacillus spp. strains
Since the leader sequence of EntA (LSentA) is of a double-
glycine type which restricts expression of the bacteriocin 
to limited LAB strains containing homologous dedicated 
ABC-transporters, we therefore employed the more ver-
satile signal peptide SPusp45 for the Sec-dependent exter-
nalization of mature EntA, as well as the use of protein 
expression vectors that permitted the inducible (pSIP409, 
pSIP411) or constitutive (pMG36c) production of the 
synthesized bacteriocin by different Lactobacillus spp. 
host strains. Thus, cloning of the lactococcal SPusp45 fused 
to mature entA (EntA) and entiA (EntI) (fragment UAI) 
into plasmids pSIP409, pSIP411 and pMG36c resulted in 
the plasmid derived vectors pSIP409UAI, pSIP411UAI 
and pMGUAI, respectively. Transformation of Lb. sakei 
Lb790, Lb. plantarum NC8 and Lb. casei CECT475 
with plasmids pSIP409UAI, pSIP411UAI and pMGUAI 
yielded recombinant Lactobacillus spp.-derived strains 
which were further checked by bacteriocinogenicity 
tests, PCR and sequencing of the inserts. Halos of inhi-
bition of variable sizes were observed by all transformed 
Lactobacillus spp. (results not shown), confirming that 
recombinant plasmids were responsible of their antimi-
crobial activity.
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The production and functional expression of the EntA 
in supernatants of the recombinant Lactobacillus spp. 
strains was quantified using specific anti-EntA antibodies 
in a NCI-ELISA, and by a microtitre plate assay (MPA). 
None of the native Lactobacillus spp. strains showed pro-
duction of EntA (Table  1). The production of EntA by 
Lb. sakei Lb790 (pSIP411UAI) and Lb. casei CECT475 
(pSIP411UAI) was 2.7- and 4.9-fold higher, respectively, 
whereas production of EntA by Lb. plantarum NC8 
(pSIP411UAI) was 4.7-times lower than production of 
EntA by the natural producer E. faecium T136. The pro-
duction of EntA by Lb. sakei Lb790, Lb. plantarum NC8 
and Lb. casei CECT475 transformed with either pSIP-
409UAI or pMGUAI, was 1.1- to 6.3-times lower than 
production of EntA by E. faecium T136 (Table 1).
When supernatants of the recombinant Lb. sakei 
Lb790, Lb. plantarum NC8 and Lb. casei CECT475 
strains were evaluated for their antimicrobial activity 
against E. faecium P13 (EntAS), the antimicrobial activ-
ity (AA) of Lb. sakei Lb790 (pSIP411UAI) was 2.2-fold 
higher while its specific antimicrobial activity (SAA) was 
1.2-times lower than the EntA produced by E. faecium 
T136 (Table  1). Lb. sakei Lb790 (pSIP409UAI) showed 
2.2-times lower AA and 1.5-times lower SAA and Lb. 
sakei Lb790 (pMGUAI) showed 15-times lower AA and 
5.5-times lower SAA, when compared to the control 
EntA producer. All Lb. plantarum NC8 recombinants 
showed a 17.1- to 38-times lower AA and 3.6- to 6.0-
times lower SAA, when compared to the control EntA 
producer. However, transformation of Lb. casei CECT475 
with plasmids pSIP409UAI, pSIP411UAI and pMGUAI 
generated supernatants with 1.3-, 22.8- and 1.2-fold 
higher AAA and 4.3-, 4.7- and 2.1-fold higher SAA, 
respectively, than those from E. faecium T136 (Table 1).
Furthermore, the evaluation of the antimicrobial activ-
ity of supernatants from the recombinant Lb. sakei Lb790, 
Lb. plantarum NC8 and Lb. casei CECT475 against five 
Listeria spp. and six L. monocytogenes strains, showed 
that supernatants from Lb. sakei Lb790 (pSIP411UAI) 
displayed 3.8-times lower to 2.7-fold higher AA whereas 
those from Lb. sakei Lb790 (pSIP409UAI) and Lb. sakei 
Lb790 (pMGUAI) showed 1.8- to 9.1-times lower and a 
6.0- to 45-times lower AA, respectively, than those from 
E. faecium T136. Supernatants from all recombinant Lb. 
plantarum NC8 strains showed a 4.9- to 120-times much 
lower AA than the control EntA producer (Table  2). 
However, despite the measurable and non-previously 
reported antimicrobial activity of Lb. casei CECT475, 
the supernatants from Lb. casei CECT475 (pSIP409UAI) 
showed 1.6- to 13.9-fold higher AA, those from Lb. 
Table 1 Bacteriocin production and antimicrobial activity of supernatants from recombinant strains
Most of the data are mean from two independent determinations in triplicate
NP no production, NA no activity, NE not evaluable
a Production of EntA was calculated by using a NCI-ELISA with polyclonal antibodies specific for EntA
b Antimicrobial activity was calculated against E. faecium P13 (EntAs). BU, bacteriocin units
c Specific antimicrobial activity refers to the antimicrobial activity against E. faecium P13 divided by the EntA produced
d Culture of E. faecium T136 used as control for production and antimicrobial activity of EntA
Strain Bacteriocin  
production  
(µg/mg cell dry weight)a
Antimicrobial  
activity  
(BU/mg cell dry weight)b
Specific antimicrobial 
activity  
(BU/µg EntA)c
Lactobacillus sakei
 Lb790 NP NA NE
 Lb790 (pSIP409UAI) 1.3 324 249
 Lb790 (pSIP411UAI) 5.2 1578 303
 Lb790 (pMGUAI) 0.7 48 68
Lactobacillus plantarum
 NC8 NP NA NE
 NC8 (pSIP409UAI) 0.4 42 105
 NC8 (pSIP411UAI) 0.4 36 90
 NC8 (pMGUAI) 0.3 19 63
Lactobacillus casei
 CECT475 NP 102 NE
 CECT475 (pSIP409UAI) 1.7 958 1629
 CECT475 (pSIP411UAI) 9.3 16,466 1771
 CECT475 (pMGUAI) 1.1 869 790
Enterococcus faecium
 T136d 1.9 721 379
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casei CECT475 (pSIP411UAI) showed 15.7- to 59.2-fold 
higher AA and those from Lb. casei CECT475 (pMGUAI) 
showed 0.54- to 4.9-fold higher AA than those from E. 
faecium T136 (Table 2).
Purification of EntA and mass spectrometry analysis
The EntA produced by Lb. sakei Lb790 (pSIP411UAI) 
and Lb. casei CECT475 (pSIP409UAI) was purified to 
homogeneity following a previously described chroma-
tographic procedure (results not shown). MALDI-TOF 
MS analysis of the purified EntA from Lb. sakei Lb790 
(pSIP411UAI) showed a major peptide fragment of a 
molecular mass of 4842.62 Da (Fig. 1a), nearly identical 
to the EntA produced by different recombinant yeasts 
[20] while the purified EntA produced by Lb. casei 
CECT475 (pSIP411UAI) showed peptide fragments of 
different molecular massess among which a peptide frag-
ment of 4844.53  Da, nearly identical to the observed 
molecular mass (4844.40 Da) of the EntA produced by E. 
faecium T136 [13], was also observed (Fig.  1b). In both 
purifications the peptide fragment of 4860.2 Da may cor-
respond to oxidation (+16 Da) of the methionine residue 
(Met33) of the EntA to methionine sulfoxide (MetSO) 
(Fig. 1). The visualization by MALDI-TOF MS of peptide 
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Fig. 1 Mass spectrometry analysis of purified enterocin A from Lb. sakei Lb790 (pSIP411UAI) (a), and Lb. casei CECT475 (pSIP411UAI) (b)
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fragments of different molecular massess (Fig.  1b) may 
suggest that the EntA produced by Lb. casei CECT475 
(pSIP411UAI) has not been purified to homogeneity or 
that these peptides could be responsible of the low anti-
microbial activity observed in supernatants of Lb. casei 
CECT475. However, treatment of crude supernatants of 
the control strain Lb. casei CECT474 with proteinase K 
(1 mg/ml) revealed that the antimicrobial activity of the 
supernatants was not of proteinaceous nature (results not 
shown).
Discussion
Lactobacilli are common colonisers of the human gas-
trointestinal and urogenital tracts, skin and the oral 
cavity and they merit recognition as starters in the 
production of fermented products, and as probiot-
ics [25, 26]. They are also being evaluated for produc-
tion of functional foods enriched in bioactive peptides 
[3]. Furthermore, production of bacteriocins by lac-
tobacilli could find their use as natural antimicrobial 
peptides while the bacteriocin-producing lactobacilli 
could be evaluated for their improved functionality as 
probiotics. Several gene expression systems have been 
developed for efficient overproduction of heterologous 
proteins in LAB [1, 27, 28]. Previous studies have evalu-
ated the production, secretion and functional expres-
sion of the EntA by different LAB, mostly of the genera 
Lactococcus, Enterococcus, and Pediococcus [13, 19, 29] 
and yeasts [20, 21]. However, of great biotechnologi-
cal interest would be the construction of recombinant 
Lactobacillus spp. for production of bacteriocins with 
known and potent antimicrobial activity against Listeria 
spp.
For protein expression by Lb. sakei and Lb. plantarum 
but also for other Lactobacillus spp., the so-called pSIP 
expression vectors permits expression of the gene of 
interest under control of an inducible promoter by an 
externally added peptide pheromone [1, 28]. The pSIP 
system has been successfully applied for intracellular 
expression, secretion and surface anchoring of a variety 
of proteins in Lb. plantarum and Lb. sakei [1]. How-
ever, although these pSIP vectors have been evaluated 
for expression of different reporter proteins, they have 
not been yet fully evaluated for secretion and functional 
expression of bacteriocins. In these vectors the expres-
sion of genes of interest is driven by strong, regulated 
promoters derived from the bacteriocin sakacin P struc-
tural gene (PsppA) or the sakacin Q structural gene (PsppQ 
also recorded as PorfX) with an engineered NcoI site for 
translational fusion cloning, as well as for components of 
the cognate two-component signal transduction system 
(SppK and SppR) which responds to an externally added 
peptide pheromone (SppIP). These vectors also carries a 
multicloning site (MCS) and the replicon derived from 
the narrow-host-range Lactobacillus replicon from plas-
mid p256 (pSIP409) or the broad-host-range, high-copy-
number replicon from plasmid pSH71 (pSIP411) [28]. 
The expression vector pMG36c contains the low copy 
replication origin of plasmid pWV01 and the strong 
P32 promoter to drive the constitutive transcription of 
inserted genes into the multicloning site (MCS) of pUC18 
[30]. Different homologous and heterologous signal pep-
tides (SPs) have been also evaluated for secretion of het-
erologous proteins and bacteriocins by LAB, although 
expression yield and secretion efficiency are not only 
steered by the SP but also the host producer [1, 10, 13].
In this work, Lb. sakei Lb790, Lb. plantarum NC8 and 
Lb. casei CECT475 were transformed with the recombi-
nant plasmids pSIP409UAI, pSIP411UAI and pMGUAI 
for heterologous production of EntA and evaluation of 
its functional expression against Listeria spp. The results 
obtained suggest that production, secretion and anti-
microbial activity of the EntA produced depend on the 
expression vector and the host strain (Table 1). EntA pro-
ducers are protected from the antagonistic effect of this 
bacteriocin by the concomitant expression of a cognate 
immunity protein (EntiA) and bacteriocins of the class 
IIa, such as the EntA use components of the mannose 
phosphotransferase system (Man-PTS) of the susceptible 
cells as the target/receptor. The immunity proteins form 
a strong complex with the receptor proteins, thereby pre-
venting cells from being killed [15, 31]. Of interest is the 
2.7- and 4.9-fold enhanced production of EntA by Lb. 
sakei Lb790 (pSIP411UAI) and Lb. casei CECT475 (pSIP-
411UAI), respectively, as compared to the rest of recom-
binant Lactobacillus spp. and E. faecium T136 (Table 1). 
The production of EntA would depend, among other fac-
tors, on plasmid stability and copy number differences 
between pSIP409, pSIP411 and pMG36c but, more likely, 
might be caused by promoters used to drive gene expres-
sion. For optimization of protein production inducible 
systems are often considered superior to constitutive 
systems since the short induction time for bacteriocin 
production from the pSIP-inducible vectors most prob-
ably prevents EntA from attaching to cell walls, forming 
aggregates, and/or undergoing protease degradation [32]. 
The high-copy number replicon of pSIP411 may be also a 
contributing factor to the higher production of EntA by 
Lactobacillus spp. recombinants transformed with pSIP-
411UAI instead of pSIP409UAI.
Protein secretion is a preferred means of protein 
expression in the development of LAB as cell factories 
for production of biologically active compounds [33]. 
However, it may happen that SPusp45 could modulate dif-
ferently the secretion of EntA by the recombinant Lb. 
sakei Lb790, Lb. plantarum NC8 and Lb. casei CECT47 
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hosts, as it appeared with secretion of EntA and other 
bacteriocins by different LAB [10, 13]. It may also happen 
that mature EntA remain N-terminally associated to the 
cell membrane of the producer cells via a Sec-type sig-
nal peptide that is not cleaved off during secretion [34]. 
The different molecular folding of EntA inside the less 
EntA-producing recombinant Lb. plantarum hosts may 
also maintain the prepeptide in an secretion-incompe-
tent conformation [35]. It is known that Lb. plantarum 
NC8 encodes three two-peptide plantaricins of narrow 
inhibitory spectra, regulated by a quorum sensing based 
network, but unable to produce bacteriocins as pure cul-
tures in liquid media [24]. Thus, variations in bacteriocin 
secretion capacities may be also governed by autoinducer 
peptide production and recognition and post-transcrip-
tional factors such as codon usage, mRNA stability and 
translational efficiency that may steer EntA production 
from the recombinant Lb. sakei Lb790 and Lb. plantarum 
NC8 [36]. New variants of the modular pSIP-vectors, 
encoding different SPs, have been tested for inducible 
gene expression and reporter protein secretion in Lacto-
bacillus spp. All recombinant strains secreted the target 
protein nuclease A (NucA), albeit with different produc-
tion levels [1].
In this work, polyclonal antibodies of predetermined 
specificity for EntA and an NCI-ELISA have permitted 
evaluation of the specific antimicrobial activity (SAA) of 
the produced EntA against E. faecium P13 (EntAS). From 
the Lb. sakei Lb790-derived recombinants, only Lb. sakei 
Lb790 (pSIP411UAI) showed a 2.2-fold higher antimi-
crobial activity (AA) but a 1.2-times lower SAA than 
the EntA produced by E. faecium T136 (Table 1). All Lb. 
plantarum NC8 recombinants showed a much lower AA 
and SAA when compared to the control EntA producer. 
However, all Lb. casei CECT475-derived recombinants 
generated supernatants with higher AA and SAA than 
those from E. faecium T136. Of interest is the 22.8-fold 
higher AA and the 4.7-fold higher SAA of supernatants 
of Lb. casei CECT475 (pSIP411UAI) (Table 1). Accord-
ing to these results, it is important to consider that not 
always a higher bacteriocin production by recombinant 
LAB may report a higher AA and SAA [9, 10]. The low 
AA and SAA of the EntA produced by the Lb. sakei 
Lb790- and Lb. plantarum NC8-hosts may depend on 
many factors which are difficult to determine. It is pos-
sible that: (1) regulatory responses to secretion stress 
activate quality control networks of the producer cells 
involving folding factors and housekeeping proteases 
[37], (2) differences in the Sec-dependent translocation 
and Sec-machinery, differences in protein folding, and 
conformational modifications of bacteriocins to a less 
extracellular active form may also decrease the antago-
nistic activity of the secreted EntA [38], (3) secretion of 
truncated bacteriocins may also lower the antimicrobial 
activity of the producer cells [10], (4) the formation of 
disulfide bonds (DSB) from the four cysteine residues 
in EntA may also play a role in the folding, structural 
integrity, and antimicrobial activity of the produced 
bacteriocin [39], and (5) the EntA contains a methio-
nine residue that may change to an apparently less active 
form due to its oxidation to methionine sulfoxide [40]. 
The lower AA and SAA of the produced EntA may be 
also adscribed to differences in protein folding efficiency 
and bacteriocin self-aggregation [13]. Although Lb. sakei 
and Lb. plantarum have been considered appropriate 
hosts for the recombinant production of a number of 
reporter proteins and enzymes [1, 41–43], the results 
of this work resolve Lb. casei CECT475 as the preferred 
host for heterologous production and functional expres-
sion of the bacteriocin EntA.
Supernatants from all recombinant Lb. casei CECT475 
hosts, producers of EntA, showed up to a 59.2-fold higher 
AA against Listeria spp. than any other Lb. sakei Lb790- 
or Lb. plantarum NC8-recombinant producer of EntA 
(Table  2). Furthermore, Lb casei CECT (pSIP411UAI) 
an inducible overproducer of EntA with higher AA and 
SAA in its supernatants than those from E. faecium 
T136, could be considered as a cellular factory and an 
alternative to E. faecium T136 for production and recov-
ery of the highly active antilisterial bacteriocin EntA. The 
controlled production of EntA by Lb. casei CECT475 
(pSIP411UAI) and the constitutive production of this 
bacteriocin by Lb. casei CECT475 (pMGUAI) could be 
also evaluated as a contributing antilisterial effect of Lb. 
casei CECT475, also cited as Lb. casei ATCC393, dur-
ing further evaluation of the potential of the Lb. casei 
CECT475-derived recombinant strains during produc-
tion of dry-fermented sausages [44, 45], production of 
antithrombotic and angiotensin converting enzyme 
(ACE)-inhibitory peptides (ACEIP) from bovine casein 
[46] or during production of antioxidant and antimuta-
genic peptides from yogurt [3].
Conclusions
The use of Lb. casei CECT475-derived strains, generally 
recognized as safe (GRAS) and with a qualified presump-
tion of safety (QPS), as recombinant bacteriocin produc-
ers may provide means by which the potential benefits of 
antimicrobial compounds can be exploited in the food 
industry, human and veterinary applications, and in the 
animal production field. The combined use of the induc-
ible protein expression vector pSIP411 and Lb. casei 
CECT475 as the producer host, would also merit recog-
nition as a novel gene expression system for the efficient 
overproduction and functional expression of EntA by Lb. 
casei.
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Methods
Microbial strains, plasmids, and growth conditions
The microbial strains and plasmids used in this study are 
listed in Table  3. Enterococcus faecium T136 was used 
as the source of entA (EntA) and entiA (EntI), whereas 
Lactococcus lactis MG1363 was the source of the signal 
peptide from protein Usp45 (SPusp45). The lactococcal 
strains were propagated at 32  °C in M17 broth (Oxoid 
Ltd., Basingstoke, UK) supplemented with 0.5  % (w/v) 
glucose (GM17). The enterococcal strains and the lac-
tobacilli were grown in MRS broth (Oxoid) at 32  °C. 
Escherichia coli XL10 Gold (Stratagene, La Jolla, CA, 
USA) was grown in BHI (Oxoid) broth at 37  °C with 
shaking. Listeria spp. strains were cultured in BHI broth 
(Oxoid) at 32  °C. Agar plates were made by addition of 
1.5 % (w/v) agar (Oxoid) to the liquid media. When nec-
essary, chloramphenicol (Sigma-Aldrich Inc., St. Louis, 
MO, USA) was added at 10 µg ml−1 for E. coli, lactococci 
and lactobacilli. Erythromicin (Sigma) was added at 
350 µg ml−1 for E. coli and at 10 µg ml−1 for lactococci 
and lactobacilli. Cell dry weights of late exponential 
phase cultures expressed as cell dry mass were deter-
mined gravimetrically.
Basic genetic techniques and enzymes
Total genomic DNA from L. lactis MG1363 and E. fae-
cium T136 was isolated using the Wizard® DNA Purifi-
cation Kit (Promega, Madison, WI, USA). Plasmid DNA 
isolation was carried out using the QIAprep Spin Mini-
prep Kit (QIAGEN, Hilden, Germany), as suggested by 
the manufacturer, but cells were suspended with lysozyme 
(40 mg ml−1) and mutanolysin (500 U ml−1) and incubated 
at 37 °C for 10 min before following the kit instructions. 
DNA restriction enzymes were supplied by New Eng-
land Biolabs (Beverly, MA, USA). Ligation reactions were 
performed with the T4 DNA ligase (Roche Molecular 
Table 3 Bacterial strains and plasmids used in this study
a ADT, agar well diffusion test; MPA, microtitre plate asay; Cmr, chloramphenicol resistance; Emr, erythromycin
b CECT, Colección Española de Cultivos Tipo (Valencia, Spain); DNBTA, Departamento de Nutrición, Bromatología y Tecnología de los Alimentos, Facultad de 
Veterinaria, Universidad Complutense de Madrid (Madrid, Spain); RUG-MG, Department of Molecular Genetics, University of Groningen (Haren, The Netherlands)
Strain or plasmid Descriptiona Source and/or 
referenceb
Strains
 Lactobacillus sakei Lb790 Host strain, meat isolate, non-bacteriocin producer [22]
 Lactobacillus plantarum NC8 Host strain, silage isolate, plasmid free [48]
 Lactobacillus casei CECT475 Host strain, cheese isolate, also recorded as strain ATCC393 CECT
 Lactococcus lactis MG1363 Source of SPusp45, plasmid-free and prophage-cured derivative of L. lactis NCDO 712 [51]
 Enterococcus faecium T136 Enterocin A and B producer, source of entA and entiA, control strain DNBTA [52]
 Enterococcus faecium P13 Enterocin P producer, control strain MPA and ADT indicator DNBTA [52]
 Listeria ivanovii CECT913 Indicator strain, sheep isolate CECT
 Listeria grayi CECT931 Indicator strain, chinchilla faeces CECT
 Listeria welshimeri CECT919 Indicator strain, decaying vegetation CECT
 Listeria seeligeri CECT917 Indicator strain, soil isolate CECT
 Listeria innocua CECT910 Indicator strain, cow brain isolate CECT
 Listeria monocytogenes CECT911 Indicator strain, spinal fluid of man CECT
 Listeria monocytogenes CECT935 Indicator strain, spinal fluid of child CECT
 Listeria monocytogenes CECT936 Indicator strain, origin not described CECT
 Listeria monocytogenes CECT939 Indicator strain, chicken isolate CECT
 Listeria monocytogenes CECT4031 Indicator strain, rabbit isolate CECT
 Listeria monocytogenes CECT4032 Indicator strain, soft cheese isolate CECT
Plasmids
 pSIP409 Emr; pSIP401 with 256rep and PorfX::gusA [28]
 pSIP411 Emr; pSIP401 with SH71rep and PorfX::gusA [28]
 pMG36c Cmr, pMG36e derivative RUG-MG [30]
 pSIP409UAI Emr; pSIP409 derivative encoding the PCR product UAI (SPusp45 fused to mature entA and 
entiA genes)
This work
 pSIP411UAI Emr; pSIP411 derivative encoding the PCR product UAI (SPusp45 fused to mature entA and 
entiA genes)
This work
 pMGUAI Cmr, pMG36c derivative encoding the SPusp45 fused to mature entA and entiA genes) [13]
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Biochemicals, Mannheim, Germany). E. coli XL10 Gold 
competent cells were transformed as described by the 
supplier (Stratagene). Competent L. lactis MG363 and 
Lactobacillus spp. cells were electrotransformed with a 
Gene PulserTM and Pulse Controller apparatus (Bio-Rad 
Laboratories, Hercules, CA, USA), according to Holo and 
Nes [47] and Aukrust and Blom [48], respectively.
PCR amplification and nucleotide sequencing
Oligonucleotide primers were obtained from Sigma-
Genosys Ltd. (Cambridge, UK). PCR-amplification of 
inserts was performed as previously described [13]. The 
PCR-generated fragments were purified by a Nucle-
oSpin® Extract II Kit (Macherey–Nagel GmbH & Co. KG, 
Düren, Germany) for cloning and nucleotide sequenc-
ing. Nucleotide sequencing of purified PCR products 
was done using the ABI PRISM® BigDyeTM Termina-
tor cycle sequence reaction kit and the automatic DNA 
sequencer ABI PRISM, model 377 (Applied Biosystems, 
Foster City, CA, USA), at the Unidad de Genómica (Fac-
ultad de Ciencias Biológicas, Universidad Complutense 
de Madrid, Madrid, Spain).
Recombinant plasmids derived from pSIP409, pSIP411 
and pMG36c
The primers and inserts used for the construction of the 
recombinant plasmids derived from pSIP409 and pSIP411 
are listed in Table 4. Plasmid derivatives were constructed 
as follows: the primer pair USPNC-F/JJ8-R was used for 
PCR-amplification from total genomic DNA of L. lactis 
MG1363 of a 124-pb NcoI fragment (UA) encoding the 
SPusp45, with a tail complementary to the DNA encoding 
the N-terminal sequence of EntA. Primers JJ3-F/JJ5-R 
were used for PCR-amplification from total genomic 
DNA of E. faecium T136 of a 475-bp XhoI fragment (AI) 
containing mature entA and entiA. Mixtures of fragments 
UA and AI were used as templates to amplify the 567-bp 
NcoI/XhoI fragment UAI encoding the mature entA and 
entiA fused to the SPusp45. Fragment UAI was digested 
with the corresponding restriction enzymes and inserted 
into either pSIP409 and pSIP411, digested with NcoI/XhoI. 
The ligation mixtures were used to transform E. coli XL10 
Gold and L. lactis MG1363 competent cells, respectively, 
and the selected plasmid derivatives pSIP409UAI and 
pSIP411UAI were checked by bacteriogenicity tests, PCR 
and sequencing of the inserts. The construction of plas-
mid pMGUAI has been described previously [13]. Plas-
mids pSIP409UAI, pSIP411UAI and pMGUAI were used 
to transform competent cells of Lb. sakei Lb790, Lb. plan-
tarum NC8 and Lb. casei CECT475.
Antimicrobial activity of the recombinant Lactobacillus 
spp. strains
The antimicrobial activity of colonies from the recombi-
nant Lactobacillus spp. strains was examined by the stab-
on-agar test (SOAT), as previously described [49]. When 
appropriate, cultures were induced with 50  ng  ml−1 of 
the inducing peptide SppIP [50] at an OD600 of, approxi-
mately, 0.3 and the induced cultures were grown at 30 °C 
for 5  h. Cell-free culture supernatants were obtained by 
centrifugation of cultures at 12,000×g at 4 °C for 10 min, 
adjusted to pH 6.2 with 1  M NaOH, filtered through 
0.2  µm pore-size filters (Whatman Int. Ltd., Maidstone, 
UK), and stored at −20  °C until use. The antimicrobial 
activity of the supernatants was quantified by a microti-
ter plate assay (MPA), as previously described [13], using 
E. faecium P13 as the indicator microorganism. With the 
MPA, growth inhibition of the sensitive culture was meas-
ured spectrophotometrically at 620  nm with a microti-
tre Labsystems iEMS plate reader (Labsystems, Helsinki, 
Finland). One bacteriocin unit (BU) was defined as the 
reciprocal of the highest dilution of the bacteriocin caus-
ing 50  % growth inhibition (50  % of the turbidity of the 
control culture without bacteriocin). The antimicrobial 
activity of the recombinant Lactobacillus spp. hosts was 
also tested against selected Listeria spp. obtained from the 
CECT (Colección Española de Cultivos Tipo, Valencia, 
Spain), using the MPA.
Table 4 Primers and PCR products used in this study
Primer or PCR  
product
Nucleotide sequence (5′–3′) or description Amplification
Primers
 JJ3-F ACCACTCATAGTGGAAAATATTATGG AI
 JJ5-R GGCGGAGCTCTCCAGGCATTAAAATTGAGATTTATCTCCATAATC AI, UA, UAI
 USPNC-F GAATTCTCACCATGGGAAAAAAAAAGATTATCTCAGCTATTTTAATGTCTAC UA, UAI
 JJ8-R CCATAATATTTTCCACTATGAGTGGTAGCGTAAACACCTGACAACGG UA
PCR products
 AI 475-bp XhoI fragment containing the mature enterocin A (entA) and immunity (entiA) genes
 UA 124-pb NcoI fragment containing the usp45 signal peptide (SPusp45) and the begining of mature entA
 UAI 567-bp NcoI/XhoI fragment containing the SPusp45 fused to mature entA and entiA
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ELISA for detection and quantification of EntA
Polyclonal antibodies with predetermined specificity 
for EntA and a non-competitive indirect enzyme-linked 
inmunosorbent assay (NCI-ELISA) were used to detect 
and quantify EntA in supernatants of the recombinant 
Lactobacillus spp. strains, essentially as described [13]. 
Briefly, wells of flat-bottom polystyrene microtitre plates 
(Maxisorp, Nunc, Roskilde, Denmark) were coated over-
night (4  °C) with supernatants from E. faecium T136 or 
the recombinant strains. After addition of the anti-EntA 
specific antibodies and the goat anti-rabbit immunoglobu-
lin G peroxidase conjugate (Cappel Laboratories, West 
Chester, PA, USA), bound peroxidase was determined with 
ABTS (2,2′-azino-bis[3-ethylbenzthiazoline-6-sulfonic acid]) 
(Sigma) as the substrate by measuring the absorbance of the 
wells at 405 nm with a Labsystems iEMS reader (Labsys-
tems) with a built-in software package for data analysis.
Purification of EntA and mass spectrometry analyses
EntA was purified from Lb. sakei Lb790 (pSIP411UAI) 
and Lb. casei CECT475 (pSIP411UAI), as previously 
described [13]. Briefly, supernatants from early station-
ary phase 1-L cultures of the recombinant Lactobacillus 
spp. strains were precipitated with ammonium sul-
fate, desalted by gel filtration, and subjected to cation-
exchange and hydrophobic-interaction chromatography, 
followed by reverse-phase chromatography in a fast-
protein liquid chromatography system (RP-FPLC) (GE 
Healthcare, Barcelona, Spain). Purified fractions were 
subjected to matrix-assisted laser desorption/ionization 
time-of-flight (MALDI-TOF) mass spectrometry, as pre-
viously described [13].
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